ClinVar Miner

Submissions for variant NM_000202.8(IDS):c.238C>T (p.Gln80Ter)

dbSNP: rs1569560527
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000781472 SCV000919529 pathogenic Mucopolysaccharidosis, MPS-II 2018-07-24 criteria provided, single submitter clinical testing Variant summary: IDS c.238C>T (p.Gln80X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 169233 control chromosomes (gnomAD). The variant, c.238C>T, has been reported in the literature in individuals affected with severe Mucopolysaccharidosis Type II (Hunter Syndrome) (Carrozzo 1996, Vafiadaki 1998, Wang 2014, Parkinson 2004). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function, by determining enzyme activity from the plasma of patients (Parkinson 2004). The most pronounced variant effect results in <10% of normal activity. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.
Invitae RCV000781472 SCV001211912 pathogenic Mucopolysaccharidosis, MPS-II 2021-08-20 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000781472 SCV002014485 pathogenic Mucopolysaccharidosis, MPS-II 2021-09-05 criteria provided, single submitter clinical testing
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, University of Padova RCV000781472 SCV005089658 pathogenic Mucopolysaccharidosis, MPS-II 2024-06-07 criteria provided, single submitter literature only Null variant (PVS1_VeryStrong), Prevalence of the variant significantly increased in affected individuals compared with controls (PS4_Supporting), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Strong)

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.